RFP
HAE icon

Root Financial Partners’s Haemonetics HAE Stock Holding History

Root Financial Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-105
Closed -$5.92K – 1581
2026
Q1 		$5.92K Buy
105
+7
+7% +$456 ﹤0.01% 1887
2025
Q4 		$7.86K Buy
98
+81
+476% +$5.44K ﹤0.01% 1604
2025
Q3 		$829 Buy
+17
New +$1.05K ﹤0.01% 2088

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Root Financial Partners's HAE Position: Q2 2026 in Review

Root Financial Partners sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 105 shares — an estimated $5.92K sold.

Root Financial Partners first reported a position in HAE in Q3 2025 and held it in 3 quarters. The position peaked at $7.86K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Root Financial Partners reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 105 Haemonetics shares in Q2 2026, an estimated $5.92K.
  • Root Financial Partners first reported a position in Haemonetics in Q3 2025 and held it in 3 quarters.
  • Root Financial Partners's Haemonetics position peaked at $7.86K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.